GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visiomed Group (XPAR:ALVMG) » Definitions » Equity-to-Asset

Visiomed Group (XPAR:ALVMG) Equity-to-Asset : 0.66 (As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Visiomed Group Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Visiomed Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €24.10 Mil. Visiomed Group's Total Assets for the quarter that ended in Dec. 2023 was €36.60 Mil. Therefore, Visiomed Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.66.

The historical rank and industry rank for Visiomed Group's Equity-to-Asset or its related term are showing as below:

XPAR:ALVMG' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.75   Med: 0.37   Max: 0.67
Current: 0.66

During the past 13 years, the highest Equity to Asset Ratio of Visiomed Group was 0.67. The lowest was -0.75. And the median was 0.37.

XPAR:ALVMG's Equity-to-Asset is ranked better than
51.61% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs XPAR:ALVMG: 0.66

Visiomed Group Equity-to-Asset Historical Data

The historical data trend for Visiomed Group's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visiomed Group Equity-to-Asset Chart

Visiomed Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -0.75 0.32 0.67 0.66

Visiomed Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.80 0.67 0.65 0.66

Competitive Comparison of Visiomed Group's Equity-to-Asset

For the Medical Instruments & Supplies subindustry, Visiomed Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visiomed Group's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visiomed Group's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Visiomed Group's Equity-to-Asset falls into.



Visiomed Group Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Visiomed Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=24.102/36.597
=0.66

Visiomed Group's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=24.102/36.597
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visiomed Group  (XPAR:ALVMG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Visiomed Group Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Visiomed Group's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Visiomed Group (XPAR:ALVMG) Business Description

Traded in Other Exchanges
Address
8, Avenue Kléber, Paris, FRA, 75116
Visiomed Group is engaged in the development, designing, and marketing of medical products. The product portfolio includes various thermometers, natural mud, cold spray, connected activity bracelets, connected scales, inhalers, humidifiers, baby flies, natural wax, comfort foam, antibacterial solutions, baby nutrition, baby accessories, among others.

Visiomed Group (XPAR:ALVMG) Headlines

No Headlines